Endo International Q3 revenue increased 18.6%Staff Writer | November 8, 2016
International reported an 18.6 percent rise in quarterly revenue, driven by higher demand for generic drugs it acquired through its purchase of Par Pharmaceuticals last year.
Endo International Total revenue rose to $884.3 million
Total revenue rose to $884.3 million from $745.7 million. ■